CPRX Catalyst Pharmaceuticals Inc

For the fiscal year ended 31/12/2022: Catalyst Pharmaceuticals Inc's revenues increased by 52.10% and amounted to 214.20M. Net income increased by 110.42% to 83.08M. Net assets increased by 45.25% to 300.42M and EPS increased from 0.37 to 0.75.